Edition:
India

Emergent Biosolutions Sees FY 2017 Revenue $555 Million To $560 Million


Monday, 8 Jan 2018 

Jan 8 (Reuters) - Emergent Biosolutions Inc ::EMERGENT BIOSOLUTIONS ANNOUNCES PRELIMINARY 2017 FINANCIAL RESULTS AND PROVIDES 2018 FINANCIAL OUTLOOK.SEES FY 2017 REVENUE $555 MILLION TO $560 MILLION.SEES Q1 2018 REVENUE $145 MILLION TO $160 MILLION.SEES FY 2017 REVENUE UP 14 PERCENT.- FOR FULL YEAR 2017, ANTICIPATES CASH AND CASH EQUIVALENTS AT YEAR END OF ABOUT $180 MILLION.- SEES 2018 TOTAL REVENUES FROM $715 MILLION TO $755 MILLION.SEES 2018 ADJUSTED NET INCOME $110 MILLION TO $125 MILLION.- FULL YEAR 2017 ADJUSTED NET INCOME IS ANTICIPATED TO BE $92 TO $96 MILLION.- FOR FULL YEAR 2017, ANTICIPATES NET INCOME OF $80 TO $84 MILLION.SEES 2018 NET INCOME $95 MILLION TO $110 MILLION.FY2017 REVENUE VIEW $547.9 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $659.4 MILLION -- THOMSON REUTERS I/B/E/S. 

Company Quote

51.06
-0.99 -1.90%
20 Sep 2019